Cannabinoids and GI Disorders: Endogenous and Exogenous

被引:0
|
作者
Zachary Wilmer Reichenbach
Ron Schey
机构
[1] Temple University,Center for Substance Abuse Research (CSAR), Lewis Katz School of Medicine
[2] Temple University,Section of Gastroenterology, Department of Medicine, Lewis Katz School of Medicine
关键词
Cannabinoids; CB1 receptor; CB2 receptor; GPR55; Irritable bowel syndrome (IBS); GI motility; Visceral hypersensitivity;
D O I
10.1007/s11938-016-0111-1
中图分类号
学科分类号
摘要
Despite the political and social controversy affiliated with it, the medical community must come to the realization that cannabinoids exist as a ubiquitous signaling system in many organ systems. Our understanding of cannabinoids and how they relate not only to homeostasis but also in disease states must be furthered through research, both clinically and in the laboratory. The identification of the cannabinoid receptors in the early 1990s have provided us with the perfect target of translational research. Already, much has been done with cannabinoids and the nervous system. Here, we explore the implications it has for the gastrointestinal tract. Most therapeutics currently on the market presently target only one aspect of the cannabinoid system. Our main purpose here is to highlight areas of research and potential avenues of discovery that the cannabinoid system has yet to reveal.
引用
收藏
页码:461 / 477
页数:16
相关论文
共 50 条
  • [21] Endogenous cannabinoids and suicide
    Sher, Leo
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 (03): : 263 - 264
  • [22] Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse
    Engler, B
    Freiman, I
    Urbanski, M
    Szabo, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02): : 608 - 617
  • [23] Elevated endogenous cannabinoids in schizophrenia
    Leweke, FM
    Giuffrida, A
    Wurster, U
    Emrich, HM
    Piomelli, D
    NEUROREPORT, 1999, 10 (08) : 1665 - 1669
  • [24] Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults
    Adams, Roy
    Oh, Esther S.
    Yasar, Sevil
    Lyketsos, Constantine G.
    Mammen, Jennifer S.
    JAMA INTERNAL MEDICINE, 2023, 183 (12) : 1324 - 1331
  • [25] ENDOGENOUS CANNABINOIDS AND NEUTROPHIL CHEMOTAXIS
    McHugh, Douglas
    Ross, Ruth A.
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 337 - 365
  • [27] Endogenous cannabinoids: Structure and metabolism
    Bisogno, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 : 1 - 9
  • [28] Endogenous cannabinoids and brain development
    Fernandez-Ruiz, J
    Hernandez, M
    Gomez, M
    Ramos, JA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S128 - S128
  • [29] Discovery and characterization of endogenous cannabinoids
    Martin, BR
    Mechoulam, R
    Razdan, RK
    LIFE SCIENCES, 1999, 65 (6-7) : 573 - 595
  • [30] Exogenous Cannabinoids, the Endocannabinoid System and Psychosis
    D'Souza, Deepak Cyril
    Skosnik, Patrick
    Cortes-Briones, Jose
    Sewell, Richard Andrew
    Radhakrishnan, Rajiv
    Mathalon, Daniel
    Cahill, John
    Gupta, Swapnil
    Ranganathan, Mohini
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 320S - 321S